Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
John W. Shiver(IGM Biosciences (United States)), Michael Citron(United States Military Academy), Jon H. Condra, Paul M. Keller(United States Military Academy), Emilio A. Emini(United States Military Academy), Melanie Horton(United States Military Academy), Joseph G. Joyce(United States Military Academy), Tong‐Ming Fu(United States Military Academy), Xiaoping Liang(United States Military Academy), Craig T. Przysiecki(United States Military Academy), Yvette Rippeon(United States Military Academy), Jason J. Z. Liao(United States Military Academy), Gwen Heidecker(United States Military Academy), Michael Chastain(United States Military Academy), Victor M. Garsky(United States Military Academy), Mary-Ellen Davies(United States Military Academy), Li Shi(United States Military Academy), Helen C. Perry(United States Military Academy), Roxana Ionescu(United States Military Academy)
Cited by 315
Related Papers
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
DNA VACCINES
|Annual Review of Immunology|1997|987